Trending

(NASDAQ: NRSN) NEUROSENSE THERAPEUDICS INC. shares are rallying more than 40% on news of positive results.

Shares are $2.42 and climbing on more than 2800 trades.

NeuroSense Therapeutics Reports Positive Results from Stage III ALS Biomarker Study

https://www.prnewswire.com/news-releases/neurosense-therapeutics-reports-positive-results-from-stage-iii-als-biomarker-study-301575706.html

The editor has bought NRSN on this news and will sell at his discretion

RelatedNews

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist